vip924
vincerx pharma
['vip924', 'vincerx']
vincerx pharma presents preclinical data on vip924, a first-in-class antibody-drug conjugate (adc), at the 2023 american association for cancer research (aacr) annual meeting $vinc 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2